Z
Ziad A. Massy
Researcher at French Institute of Health and Medical Research
Publications - 443
Citations - 22097
Ziad A. Massy is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Kidney disease & Population. The author has an hindex of 66, co-authored 386 publications receiving 18117 citations. Previous affiliations of Ziad A. Massy include University of Paris-Sud & Public Health Research Institute.
Papers
More filters
Journal ArticleDOI
A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease
Denis Fouque,Kamyar Kalantar-Zadeh,Joel D. Kopple,Noël Cano,Philippe Chauveau,Lilian Cuppari,Harold A. Franch,Gabriele Guarnieri,Talat Alp Ikizler,George A. Kaysen,Bengt Lindholm,Ziad A. Massy,William E. Mitch,E. Pineda,Peter Stenvinkel,A. Trevinho-Becerra,Christoph Wanner +16 more
TL;DR: An expert panel to review and develop standard terminologies and definitions related to wasting, cachexia, malnutrition, and inflammation in CKD and AKI recommends the term 'protein-energy wasting' for loss of body protein mass and fuel reserves.
Journal ArticleDOI
Review on uremic toxins: Classification, concentration, and interindividual variability
Raymond Vanholder,Rita De Smet,Griet Glorieux,Àngel Argilés,Ulrich Baurmeister,Philippe Brunet,William R. Clark,Gerald Cohen,Peter Paul De Deyn,Reinhold Deppisch,Béatrice Descamps-Latscha,Thomas Henle,Achim Jörres,Horst Dieter Lemke,Ziad A. Massy,Jutta Passlick-Deetjen,Mariano Rodriguez,Bernd Stegmayr,Peter Stenvinkel,Ciro Tetta,Christoph Wanner,Walter Zidek +21 more
TL;DR: Concentrations of retention solutes in uremia vary over a broad range, from nanograms per liter to grams per liter, and a substantial number of molecules are protein bound and/or middle molecules, and many of these exert toxicity and are characterized by a high range of toxic over normal concentration (CU/CN ratio).
Journal ArticleDOI
Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease Patients
Fellype C. Barreto,Daniela V. Barreto,Sophie Liabeuf,Natalie Meert,Griet Glorieux,Mohammed Temmar,Gabriel Choukroun,Raymond Vanholder,Ziad A. Massy +8 more
TL;DR: The study presented here indicates that IS may have a significant role in the vascular disease and higher mortality observed in CKD patients.
Journal ArticleDOI
Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?
Peter Stenvinkel,Juan Jesus Carrero,Jonas Axelsson,Bengt Lindholm,Olof Heimbürger,Ziad A. Massy +5 more
TL;DR: This review focuses on the many new pieces that need to be fit into the complicated puzzle of uremic vascular disease, including persistent inflammation, endothelial dysfunction, oxidative stress, and vascular ossification, which are not only highly prevalent in CKD but also more strongly linked to CVD in these patients than in the general population.
Journal ArticleDOI
Cognitive Disorders and Dementia in CKD: The Neglected Kidney-Brain Axis
Jean-Marc Bugnicourt,Olivier Godefroy,Jean-Marc Chillon,Jean-Marc Chillon,Gabriel Choukroun,Ziad A. Massy,Ziad A. Massy +6 more
TL;DR: The prevalence and characteristics of cognitive disorders and dementia in patients with CKD, brain imaging findings, and traditional and nontraditional risk factors are discussed.